Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Project Oncology®
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Brian P. McDonough, MD, FAAFP; Andrew E. Hendifar, MD
- Brian P. McDonough, MD, FAAFP
- Andrew E. Hendifar, MD
Key Differences in Pulmonary and Extrapulmonary NEC Management
Key Differences in Pulmonary and Extrapulmonary NEC Management
Project Oncology®
Key Differences in Pulmonary and Extrapulmonary NEC Management
Alexandria May, PharmD, BCPS; Lowell B. Anthony, MD, FACP
- Alexandria May, PharmD, BCPS
- Lowell B. Anthony, MD, FACP
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Project Oncology®
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP; Rohit Thummalapalli, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Rohit Thummalapalli, MD
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
1.50 credits
MinuteCE®
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
Jennifer Johnson, MD, PhD; Adam J. Luginbuhl, MD
0.50 credits 5 episodes
- Jennifer Johnson, MD, PhD
- Adam J. Luginbuhl, MD
0.50 credits 5 episodes
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
MinuteCE®
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
0.50 program credits
- Jennifer Johnson, MD, PhD
0.50 program credits
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
MinuteCE®
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Adam J. Luginbuhl, MD; Jennifer Johnson, MD, PhD
0.50 program credits
- Adam J. Luginbuhl, MD
- Jennifer Johnson, MD, PhD
0.50 program credits
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Project Oncology®
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Amy Comander, MD
- Amy Comander, MD

Medical News

Medical News
ctDNA-Guided Atezolizumab Extends Survival After Cystectomy
06/01/2026
Read more
Medical News
Phase 2 Core-008 Readout of Cretostimogene Plus Gemcitabine in NMIBC
06/01/2026
Read more
Medical News
Amivantamab Plus Lazertinib in EGFR-Mutant Lung Cancer with CNS Metastases
05/28/2026
Read more
Medical News
Molecular Profiling Guides Adjuvant Therapy in Endometrial Cancer
05/25/2026
Read more

CME/CE

Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
0.50 program credits
- Adam J. Luginbuhl, MD
0.50 program credits
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CE
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
CME/CE Virtual Event
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
June 05, 2026
05:00 PM - 05:45 PM CEST
0.75 credits
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
CME/CE Virtual Event
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
June 17, 2026
04:30 PM - 05:15 PM CEST
0.75 credits

Clinical Practice

Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Project Oncology®
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Alexandria May, PharmD, BCPS; Chandrikha Chandrasekharan, MBBS
- Alexandria May, PharmD, BCPS
- Chandrikha Chandrasekharan, MBBS
Optimizing Treatment Intensity in Early-Stage TNBC
Optimizing Treatment Intensity in Early-Stage TNBC
Project Oncology®
Optimizing Treatment Intensity in Early-Stage TNBC
Roberto Leon-Ferre, MD
- Roberto Leon-Ferre, MD
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Project Oncology®
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Amy Comander, MD
- Amy Comander, MD
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
MinuteCE®
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
0.50 program credits
- Adam J. Luginbuhl, MD
0.50 program credits

Programs

Matching TNBC Treatment Intensity to Patient Needs
Matching TNBC Treatment Intensity to Patient Needs
Project Oncology®
Matching TNBC Treatment Intensity to Patient Needs
Roberto Leon-Ferre, MD
- Roberto Leon-Ferre, MD
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Project Oncology®
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Daniel Hertz, PhD, PharmD
- Daniel Hertz, PhD, PharmD
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Deepa Rangachari, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Deepa Rangachari, MD
Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®
Managing Immune-Related Adverse Events in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Paul Bunn, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Paul Bunn, MD